Cloudways Demonstrates Growth Ambitions with Customer Momentum, New Features, and Key Executive Hires
2.6.2022 10:00:00 EEST | Business Wire | Press release
Cloudways (cloudways.com), the leading cloud hosting provider focused on simplicity, flexibility, and performance, announces significant customer momentum ahead of their presence at WordCamp Europe. Cloudways’ announcements at WordCamp Europe include SafeUpdates (in beta), new automations that manage WordPress updates at scale, and partnership with Astra Pro, a collaboration allowing users to build websites faster and easier than ever before.
Cloudways supports over 70k customers and 500K+ websites and was recently rated by G2 as the best cloud hosting company for SMBs with a rating of 4.8 out of 5. Additionally, Cloudways has strengthened its executive team with the hire of ex-Microsoft executive Paul Haverstock as VP of Engineering, Bluehost executive Suhaib Zaheer as COO, and AWS executive Tom Erskine as CMO. Cloudways has significantly grown in size to more than 280 employees, with its global mindset reflected in an employee base coming from 20+ countries.
Cloudways focuses on giving agencies, SMBs, e-commerce providers, and individuals a hassle-free, premium experience to help them grow their business with both peace of mind and improved productivity. The Cloudways platform features >99.9% uptime, fast page load times, pro-active app monitoring, dedicated workflows, leading security with add-ons from Cloudflare, and 24/7 premium support. Great value and flexibility are also key platform features with pay-as-you-go plans offered from cloud providers including AWS, Google Cloud, Linode, Vultur, and Digital Ocean and a choice of 65+ Data Center locations.
SafeUpdates, which is being launched in beta, is Cloudways’ newest feature and will enable agencies and developers to update their WordPress websites both automatically and on demand. The workflow secures a backup, performs advanced visual regression testing and performance checks on both staging and live, and then deploys selected updates to production or automatically rolls back the changes in case of any issues. SafeUpdates allows agencies and developers to automate their work, focus on their business, and upsell maintenance services with confidence.
Cloudways’ partnership with Astra Pro is part of a series of collaborations the company has made in recent months to enhance WordPress simplicity and ensure maximum performance and security on its platform. Cloudways has worked closely with Cloudflare, OceanWP, Divi, and OCP among others to offer a seamless, no-code digital experience for agencies and developers to build and secure WordPress websites.
“Cloudways is both growing as a company and building significant momentum in the cloud hosting industry,” said Aaqib Gadit, Co-Founder and CEO of Cloudways. “The recent addition of Suhaib, Tom, and Paul to our leadership team shows the growth plans and ambition we have for Cloudways. At Cloudways, we are deeply focused on being a trusted partner to our customers and are continually innovating to save them both time and money while delivering a great user experience.”
To learn more, visit Cloudways’ booth at WordCamp Europe at https://www.cloudways.com/en/wordcamp-europe.php
About Cloudways:
Founded in 2012, Cloudways is an intuitive, one-click managed cloud hosting platform that hosts over 50,000 servers globally. G2’s Best Managed Hosting Provider for 2021, the platform lets users host WordPress and WooCommerce websites on top of a variety of cloud-hosting providers, including Google Cloud, Amazon Web Services, DigitalOcean, Vultr, and Linode. The platform features a web app management function that easily launches cloud servers for the deployment of WordPress, Magento, and PHP. Visit the company website at https://www.cloudways.com/en/about_us.php
# # #
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005120/en/
Contact information
Cloudways Media Contact:
Lauren Perry
SlicedBrand for Cloudways
lauren@slicedbrand.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom